Literature DB >> 20536452

Progression of ocular sulfur mustard injury: development of a model system.

Denise Milhorn1, Tracey Hamilton, Marian Nelson, Patrick McNutt.   

Abstract

Exposure of tissues to sulfur mustard (SM) results in the formation of protein and nucleotide adducts that disrupt cellular metabolism and cause cell death. Subsequent pathologies involve a significant proinflammatory response, disrupted healing, and long-term defects in tissue architecture. Following ocular exposure, acute corneal sequelae include epithelial erosions, necrosis, and corneal inflammation. Longer term, a progressive injury becomes distributed throughout the anterior chamber, which ultimately causes a profound remodeling of corneal tissues. In many cases, debilitating and vision-threatening injuries reoccur months to years after the initial exposure. Preliminary data in humans suffering from chronic epithelial lesions suggest that thymosin beta4 (Tbeta4) may be a viable candidate to mitigate acute or long-term ocular SM injury. To evaluate therapeutic candidates, we have developed a rabbit ocular exposure model system. In this paper, we report molecular, histological, ultrastructural, and clinical consequences of rabbit ocular SM injury, which can be used to assess Tbeta4 efficacy, including timepoints at which Tbeta4 will be assessed for therapeutic utility.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536452     DOI: 10.1111/j.1749-6632.2010.05491.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

Review 1.  Corneal toxicity induced by vesicating agents and effective treatment options.

Authors:  Dinesh G Goswami; Neera Tewari-Singh; Rajesh Agarwal
Journal:  Ann N Y Acad Sci       Date:  2016-06-21       Impact factor: 5.691

2.  Silibinin, dexamethasone, and doxycycline as potential therapeutic agents for treating vesicant-inflicted ocular injuries.

Authors:  Neera Tewari-Singh; Anil K Jain; Swetha Inturi; David A Ammar; Chapla Agarwal; Puneet Tyagi; Uday B Kompella; Robert W Enzenauer; J Mark Petrash; Rajesh Agarwal
Journal:  Toxicol Appl Pharmacol       Date:  2012-07-24       Impact factor: 4.219

3.  Histopathological and Molecular Changes in the Rabbit Cornea From Arsenical Vesicant Lewisite Exposure.

Authors:  Neera Tewari-Singh; Dinesh G Goswami; Rama Kant; David A Ammar; Dileep Kumar; Robert W Enzenauer; Robert P Casillas; Claire R Croutch; J Mark Petrash; Rajesh Agarwal
Journal:  Toxicol Sci       Date:  2017-12-01       Impact factor: 4.849

4.  Clinical progression of ocular injury following arsenical vesicant lewisite exposure.

Authors:  Neera Tewari-Singh; Claire R Croutch; Richard Tuttle; Dinesh G Goswami; Rama Kant; Eric Peters; Tara Culley; David A Ammar; Robert W Enzenauer; J Mark Petrash; Robert P Casillas; Rajesh Agarwal
Journal:  Cutan Ocul Toxicol       Date:  2016-03-22       Impact factor: 1.820

Review 5.  Contributions of tissue-specific pathologies to corneal injuries following exposure to SM vapor.

Authors:  Patrick M McNutt; Kaylie M Tuznik; Elliot J Glotfelty; Marian R Nelson; Megan E Lyman; Tracey A Hamilton
Journal:  Ann N Y Acad Sci       Date:  2016-06-16       Impact factor: 5.691

6.  Nitrogen Mustard-Induced Corneal Injury Involves DNA Damage and Pathways Related to Inflammation, Epithelial-Stromal Separation, and Neovascularization.

Authors:  Dinesh G Goswami; Neera Tewari-Singh; Deepanshi Dhar; Dileep Kumar; Chapla Agarwal; David A Ammar; Rama Kant; Robert W Enzenauer; J Mark Petrash; Rajesh Agarwal
Journal:  Cornea       Date:  2016-02       Impact factor: 2.651

7.  Quantitative RT-PCR profiling of the rabbit immune response: assessment of acute Shigella flexneri infection.

Authors:  Pamela Schnupf; Philippe J Sansonetti
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

Review 8.  Ocular toxicity of mustard gas: A concise review.

Authors:  Allison Fuchs; Elizabeth A Giuliano; Nishant R Sinha; Rajiv R Mohan
Journal:  Toxicol Lett       Date:  2021-02-15       Impact factor: 4.271

9.  Architectural and biochemical expressions of mustard gas keratopathy: preclinical indicators and pathogenic mechanisms.

Authors:  Patrick McNutt; Megan Lyman; Adam Swartz; Kaylie Tuznik; Denise Kniffin; Kim Whitten; Denise Milhorn; Tracey Hamilton
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

10.  A Novel Topical Ophthalmic Formulation to Mitigate Acute Mustard Gas Keratopathy In Vivo: A Pilot Study.

Authors:  Ratnakar Tripathi; Praveen K Balne; Nishant R Sinha; Lynn M Martin; Sabeeh Kamil; James R Landreneau; Suneel Gupta; Jason T Rodier; Prashant R Sinha; Nathan P Hesemann; Alexandria C Hofmann; Michael K Fink; Shyam S Chaurasia; Rajiv R Mohan
Journal:  Transl Vis Sci Technol       Date:  2020-11-02       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.